vaccines

What you need to know about the coronavirus right now

Sensex, Nifty the highest level when the country approves COVID-19 vaccines

The U.S. could cut some doses of Moderna vaccine in half to speed up, an official says

England enters a new lock as COVID-19 variable rampages

Authorities remain at the forefront of new COVID cases

COVID-19: A global vaccine stripped down by nationality and profit-making

Brazil to introduce 2 million doses of AstraZeneca vaccine, not yet approved for use

CEO of Leumit HMO: “We have developed vaccines for chronic patients aged 50-60”

Edelstein: “We are in a more severe eruption than in September”

From Stocks to Bitcoin, investors promise to follow the ‘Everything Rally’